Alternatives

Both will employ index put writing strategies

AUM has grown to $2bn in a year

Daniel Koller, BB Biotech's head of investment, discusses sector growth, innovation and the attractive valuations of fast-growing companies.

Currency gains added to performance

Ferreira re-joining

Inflows of $2bn

Demand for alternative income

Quants come with their own performance risks

Aim to double UK business

Focus on utilities and telecoms